SYSTM Wealth Solutions LLC Sells 10,489 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

SYSTM Wealth Solutions LLC decreased its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 15.2% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 58,558 shares of the company’s stock after selling 10,489 shares during the quarter. SYSTM Wealth Solutions LLC’s holdings in Ryan Specialty were worth $3,391,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of RYAN. Champlain Investment Partners LLC raised its stake in Ryan Specialty by 28.0% during the first quarter. Champlain Investment Partners LLC now owns 4,937,332 shares of the company’s stock valued at $274,022,000 after purchasing an additional 1,079,505 shares in the last quarter. Norden Group LLC raised its stake in Ryan Specialty by 2,138.1% during the first quarter. Norden Group LLC now owns 778,848 shares of the company’s stock valued at $43,226,000 after purchasing an additional 744,049 shares in the last quarter. Bessemer Group Inc. raised its stake in Ryan Specialty by 33.9% during the first quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company’s stock valued at $106,886,000 after purchasing an additional 488,067 shares in the last quarter. Bank of New York Mellon Corp raised its stake in Ryan Specialty by 132.2% during the second quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company’s stock valued at $48,425,000 after purchasing an additional 476,126 shares in the last quarter. Finally, Norges Bank purchased a new stake in Ryan Specialty during the fourth quarter valued at $16,964,000. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Trading Down 1.4 %

RYAN stock opened at $63.57 on Wednesday. The company has a market capitalization of $16.62 billion, a PE ratio of 119.95, a P/E/G ratio of 1.51 and a beta of 0.62. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $69.03. The firm’s 50-day moving average is $62.66 and its 200 day moving average is $57.07. The company has a debt-to-equity ratio of 1.81, a current ratio of 1.09 and a quick ratio of 1.09.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.56 by $0.02. The company had revenue of $695.40 million for the quarter, compared to the consensus estimate of $695.56 million. Ryan Specialty had a net margin of 10.21% and a return on equity of 48.08%. The firm’s revenue was up 18.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.45 EPS. On average, research analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.81 EPS for the current year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, August 27th. Investors of record on Tuesday, August 13th were paid a $0.11 dividend. This represents a $0.44 annualized dividend and a yield of 0.69%. The ex-dividend date was Tuesday, August 13th. Ryan Specialty’s dividend payout ratio is presently 83.02%.

Insider Buying and Selling

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 5,375 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $64.73, for a total transaction of $347,923.75. Following the transaction, the director now directly owns 2,685 shares in the company, valued at approximately $173,800.05. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 5,375 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $64.73, for a total transaction of $347,923.75. Following the transaction, the director now directly owns 2,685 shares in the company, valued at approximately $173,800.05. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, President Timothy William Turner sold 2,000,000 shares of the stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $62.45, for a total transaction of $124,900,000.00. Following the transaction, the president now owns 8,095 shares in the company, valued at $505,532.75. The disclosure for this sale can be found here. Insiders have sold 2,107,136 shares of company stock valued at $131,860,032 in the last 90 days. Company insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on RYAN shares. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and set a $62.00 price target on shares of Ryan Specialty in a research note on Tuesday, July 2nd. UBS Group upped their price target on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research note on Tuesday, August 13th. Barclays started coverage on shares of Ryan Specialty in a research note on Wednesday, September 4th. They issued an “overweight” rating and a $76.00 target price on the stock. Wells Fargo & Company increased their target price on shares of Ryan Specialty from $60.00 to $63.00 and gave the company an “equal weight” rating in a research note on Friday, August 2nd. Finally, Citigroup increased their target price on shares of Ryan Specialty from $56.00 to $62.00 and gave the company a “neutral” rating in a research note on Tuesday, July 23rd. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $63.40.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.